Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter: Confirmatory Validation of QASICC Questionnaire
QASICC Questionnaire The QASICC questionnaire included 27 questions (Q) assessing seven
dimensions: pain during placement or use (Q1, Q2), contribution to the comfort of the
treatment (Q3, Q4, Q7, Q10, Q12), esthetics and privacy (Q5, Q6, Q8, Q11, Q17, Q19), the
impact on professional activities, social and sports (Q9, Q13, Q14, Q18, Q20), the impact on
daily activities (Q15, Q16, Q21, Q22 ), local discomfort (Q23, Q24, Q25, Q26) and overall
satisfaction (Q27). The device-related answers were of two types: Likert or visual analogue
scale. Four types of Likert response were available: "no", "low," "moderate,"
"significant,"/"never," "sometimes," "often," "always "/" very easy "," easy "," difficult
"," very difficult "/" not at all "," somewhat "," a lot "," extremely ". These questions
are scored 0, 33, 67, 100, respectively, when the scores are correlated with symptoms, or
100, 67, 33, 0 when the scores are inversely correlated with symptoms. Visual analog scales
(VAS) have a length of 100 mm. The score represents the number of mm measured on the scale.
A mean score of acceptance and satisfaction can be calculated on a scale of 0 to 100 for all
seven dimensions using the following formula: {(100-score DO) + CO + score (score ES-100) +
(100-PR score) + (100-ES score) + (score 100-IN) + SA score} / 7. The higher the overall
score, the greater the acceptance and satisfaction
The questionnaire is administered to the patient 30 days (+/-7 days) after CVC implantation.
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label
QASICC questionnaire's 27 items tested on 990 patients to confirm the internal structure
Items quality Dimensional structure Dimensional consistence Measure accuracy Measure reliability Sensitivity to change
30 days (+/- 7 days) after CVC implantation
No
PIERRE YVES MARCY, MD
Principal Investigator
Centre Antoine Lacassagne
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
2011-A01063-38
NCT01616537
November 2011
December 2013
Name | Location |
---|